Ovagen
- Category
- Bioregulators
- Administration routes
- InjectableOral
- Regulatory status
- Not FDA-approved
What it is
Ovagen is a synthetic tripeptide marketed for liver, kidney, and gut protection plus anti-aging effects via gene regulation. Evidence is speculative, resting on mechanistic and animal studies rather than controlled human trials, so benefits remain unproven in people. There is no human safety data and long-term effects are unknown. It is not an approved US drug, and available product is unregulated, purity uncertain.
Read Full recordStudied uses & evidence
Studied uses(4)
Anti-aging effects at the cellular level
LowSingle-lab rat kidney cell studies show reduced aging markers; no lifespan or human data.
Nephroprotective effects
LowMultiple animal studies show kidney protection in injury models; no human trials yet.
GI mucosal protection
SpeculativeNo study of this peptide in gastrointestinal tissue; claim is purely theoretical.
Evidence limits
- Evidence Level
- Preclinical
All published research on EDL (Ovagen) is preclinical — in vitro cell culture and animal (rat) models. No registered clinical trials. The broader Khavinson program has extensive Russian clinical experience, but for other peptides (Thymalin, Cortexin), not Ovagen specifically.
Benefits = confidence in the evidence: High · Medium · Low · Speculative (High requires human randomized trials for that specific benefit)
Cautions & risk summary
General cautions
Pregnancy or breastfeeding
AbsoluteNo human reproductive safety data exists for this peptide. Effects on fetal development are unknown.
Children under 18
AbsoluteNo pediatric safety data. Not recommended for use in minors.
Known hypersensitivity
AbsoluteDiscontinue immediately if allergic reaction occurs (rash, swelling, difficulty breathing).
Risk summary(5)
Risks = level of concern: High · Moderate · Low · Theoretical
No human clinical safety data
HighUnregulated product quality
HighUnknown long-term effects
ModerateTheoretical epigenetic risks
TheoreticalContraindicated in pregnancy/breastfeeding
Moderate
Further reading
- Overview in Full record
- Safety & interactions in Full record
- Research & benefits in Full record
- Regulation & availability in Full record
- Sources in Full record
- Frequently asked questions in Full record
This is educational content compiled from published research, not medical advice. Always consult a licensed healthcare provider before using any peptide. Medical disclaimer
Compiled from published research indexed through March 2026.